APO-Metaraminol metaraminol (as tartrate) 10 mg/1 mL solution for injection ampoule

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

metaraminol tartrate, Quantity: 18.976 mg (Equivalent: metaraminol, Qty 10 mg)

Disponible des:

Arrotex Pharmaceuticals Pty Ltd

formulario farmacéutico:

Injection, solution

Composición:

Excipient Ingredients: sodium metabisulfite; water for injections; sodium chloride

Vía de administración:

Intravenous

Unidades en paquete:

5

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma.,It may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

Resumen del producto:

Visual Identification: clear colorless solution; Container Type: Ampoule; Container Material: Glass; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Estat d'Autorització:

Registered

Data d'autorització:

2019-09-26